June 23, 2026 · Form 4 insider transaction
Bizily Scott bought 9,810 shares of 4D Molecular Therapeutics, Inc. at $4.14 per share, a transaction worth $40.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Reflects 5,023 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.